期刊文献+

非HDLC/HDLC与2型糖尿病患者早期颈动脉斑块的相关性 被引量:5

Non-HDLC /HDLC Is Associated with Early Carotid Artery Plaque in Patients with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的评价非高密度脂蛋白胆固醇/高密度脂蛋白胆固醇(非HDLC/HDLC)等血脂指标与2型糖尿病患者早期颈动脉斑块发生的相关性。方法回顾性分析1021例无心脑血管疾病病史的2型糖尿病患者。B超判断颈动脉斑块及测量斑块面积。比较颈动脉斑块组与无斑块组的基本资料、糖尿病病程、糖化血红蛋白、非HDLC/HDLC等血脂比值指标。分析不同血脂指标与颈动脉斑块的相关性。受试者作业特征曲线(ROC)分析非HDLC/HDLC等血脂指标对颈动脉斑块的预测价值。在斑块组,评价非HDLC/HDLC等血脂指标与斑块面积的相关性。结果斑块组男性比率、年龄、糖尿病病程、收缩压、非HDLC、非HDL/HDLC、总胆固醇(TC)/HDLC和LDLC/HDLC显著高于无斑块组,但斑块组的HDLC水平显著低于无斑块组,上述差异有统计学意义(P<0.05)。Logistc回归分析示调整混杂因素后非HDLC水平、非HDLC/HDLC、TC/HDLC和LDLC/HDLC分别是颈动脉斑块的独立危险因素(P<0.05)。LDLC水平在调整混杂因素后与颈动脉斑块无相关性。将非HDLC/HDLC与其他血脂指标的ROC曲线下面积进行比较:非HDLC/HDLC高于LDLC/HDLC、TC/HDLC,但差异接近有统计学意义(P值分别为0.052和0.058)。非HDLC/HDLC显著高于非HDLC和LDLC(P均<0.001)。在斑块组,多元回归分析显示非HDLC/HDLC和LDLC/HDLC是斑块面积的独立影响因子(P<0.05),而非HDLC和TC/HDLC在调整混杂因素后与斑块面积无相关性。结论非HDLC/HDLC是评估2型糖尿病患者早期颈动脉斑块的良好血脂指标。 Aim To evaluate the relation between non-high density lipoprotein cholesterol (non-HDLC)/HDLC and early carotid plaque in type 2 diabetes patients. Methods 1021 type 2 diabetes patients without history of cardio- vascular disease were retrospectively analyzed. Carotid plaque and plaque area were measured by B ultrasound. The general data, duration of diabetes, glycosylated hemoglobin, low density lipoprotein cholesterol ( LDLC), HDLC, non- HDLC and the lipid ratios were compared in the group with carotid plaques and without plaques. The relation between se- rum lipid parameters and carotid artery plaque was analysed. The prediction power of the lipid parameters on carotid ar- tery plaque were analysed by receiver operating characteristic curve ( ROC ). In the group with carotid plaques, the cor- relation of the lipid parameters and plaque area were anayzed. Results The male ratio, age, duration of diabetes, systolic blood pressure, non-HDLC levels, non-HDL/HDLC, total cholesterol(TC)/HDLC and LDLC/HDLC were signifi- cantly higher in the group with paques than the group without plaques. However, the HDLC level was significantly lower in the group with plaques than the group without plaques. The difference of the above was statistically significant ( P 〈 0. 05). Logistc regression analysis showed that non-HDLC levels, non-HDLC/HDLC, TC/HDLC and LDLC/HDLC were independent risk factors for carotid plaque (P 〈 0. 05). There were no correlation between LDLC levels and carotid plaques after adjustment for confounding factors. The area under ROC curve of non-HDLC/HDLC and other lipid parameters were compared: non-HDLC/HDLC was higher than that of LDLC/HDLC, TC/HDLC, but the difference was close to statis- tical significance (P = 0. 052 and 0. 058). Non-HDLC/HDLC was significantly higher than that of HDLC and LDLC (P 〈 0. 001 ). In the group with plaques, muhiple regression analysis showed non-HDLC/HDLC and LDLC/HDLC were the independent impact factors (P 〈 0. 05) for plaque a
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2013年第8期716-720,共5页 Chinese Journal of Arteriosclerosis
基金 国家自然科学青年基金(81100587)
关键词 非高密度脂蛋白胆固醇 高密度脂蛋白胆固醇 糖尿病 颈动脉斑块 Non-high Density Lipoprotein Cholesterol/High Density Lipoprotein Cholesterol Diabetes CarotidPlaque
  • 相关文献

参考文献18

  • 1杜小平,夏健,杨期东,许宏伟.胰岛素抵抗与脑血管病危险因素聚集性关系的研究[J].湖南医科大学学报,2000,25(2):163-165. 被引量:17
  • 2冯琼,周智广,唐炜立,杨晓琳,龙欣.3种代谢综合征工作定义在男性健康体检者中的比较[J].中南大学学报(医学版),2005,30(2):130-134. 被引量:19
  • 3Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the third report of the National Cholesterol Education Pro- gram (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel m) J]. JAMA, 2001, 285 (19) : 2 486-497. 被引量:1
  • 4American Diabetes Association. Standards of medical care in diabetes 2013 [ J ]. Diabetes Care, 2013, 36 ( Suppl 1) : S11-66. 被引量:1
  • 5Reiner , Catapano AL, De Backer G, et al. Clinical Prac- tice Guidelines Committee of the Spanish Society of Cardiol- ogy. ESC/EAS Guidelines for the management of dyslipi- daemias[J]. Rev Esp Cardiol, 2011,64(12): 1 168. 被引量:1
  • 6Farwell WR, Sesso HD, Buring JE, et al. Non-high-densi- ty lipoprotein cholesterol versus low-density lipoprotein cho- lesterol as a risk factor for a first nonfatal myocardial infarc- tion[J]. Am J Cardiol, 2005, 96:1 129-134. 被引量:1
  • 7Di Angelantonio E, Sarwar N, Perry P, et al. Major lip- ids, apolipoproteins, and risk of vascular disease. Emer- ging Risk Factors Collaboration [ J ]. JAMA, 2009, 302 (18): 1 993-2000. 被引量:1
  • 8Eliasson B, Cederholm J, Eeg-Olofsson K, et al. Clinical usefulness of different lipid measures for prediction of coro- nary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register [ J ]. Diabetes Care, 2011, 34(9) : 2 095-100. 被引量:1
  • 9Taskinen MR, Barter PJ, Ehnholm C, et al. FIELD study investigators. Ability of traditional lipid ratios and apoli- poprotein ratios to predict cardiovascular risk in people with type 2 diabetes [J]. Diabetologia, 2010, 53:1 846 - 855. 被引量:1
  • 10Hayashino Y, Jackson JL, Fukumori N, et al. Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: a meta-a- nalysis of randomized controlled trials [ J ]. Diabetes Res Clin Pract, 2012, 98 (3) : 349-360. 被引量:1

二级参考文献13

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2126
  • 2叶任高.内科学[M](第5版)[M].北京:人民卫生出版社,2000.313. 被引量:256
  • 3Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease[J]. Diabetes, 1988,37(12):1595-1607. 被引量:1
  • 4Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertri-glyceridemia, and hypertension[J]. Arch Intern Med, 1989, 149(7): 1514-1520. 被引量:1
  • 5DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease[J]. Diabetes Care, 1991, 14(3): 173-194. 被引量:1
  • 6World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus[R]. WHO: Geneva, 1999. 被引量:1
  • 7National Institutes of Health: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ). Executive Summary[R]. Bethesda: National Institutes of Health, National Heart, Lung and Blood Institute, 2001. 被引量:1
  • 8Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third national health and nutrition examination survey[J]. JAMA, 2002, 287(3): 356-359. 被引量:1
  • 9Ford ES, Giles WH.A comparison of the metabolic syndrome using two proposed definitions [J]. Diabetes Care, 2003, 26(3): 575-581. 被引量:1
  • 10Bonora E, Kiechl S, Willeit J. Prevalence of insulin resistance in metabolic disorders. The Bruneck Study[J]. Diabetes, 1998, 47(10): 1643-1649. 被引量:1

共引文献34

同被引文献48

  • 1Bozina T, Simic I, Lovric J, et 81. Effects of lipopretein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits [J]. Coil Antropol, 2013, 37(3): 801-808. 被引量:1
  • 2Kriska T, Ccpura C, Ganthicr KM, et al. Role of maerophage PPARgamma in experimental hypertension [ J]. Am J Physiol Heart Cire Physiol, 2014, 306( 1 ): H26-32. 被引量:1
  • 3Neeulai D, Schwake M, Raviehandran M, et al. Structure of LIMP- 2 provides functional insights with implications for SR-B I and CD36 [J]. Nature, 2013, 504(7478): 172-176. 被引量:1
  • 4Afonso Mda S, Castitho G, Lavrador MS, et al. The impact of diet- ary fatty acids on macrophage cholesterol homeostasis [ J ]. J Nutr Biochcm, 2014, 25(2) : 95-103. 被引量:1
  • 5Chavez-Sanchez L, Garza-Reyes MG, Espinosa-Luna JE, et al. The role of TLR2, TLR4 and CD36 in macrephage activation and foam cell formation in response to oxLDL in humans [J]. Hum Immunol, 2014, 75(4): 322-329. 被引量:1
  • 6Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010 [ J]. Diabetes Res Clin Pract, 2010, 87(1 ) : 15-19. 被引量:1
  • 7Ciofll G, Rossi A, Targher G, et al. Usefulness of subclinical left ventricular midwall dysfunction to predict cardiovascular mortality in patients with type 2 diabetes mellitus [J]. Am J Cardiol, 2014, 113(8) :1409-1414. 被引量:1
  • 8Lamri L, Gripiotis E, Ferrario A. Diabetes in algeria and challenges for health policy: a literature review of prevalence, cost, manage- ment and outcomes of diabetes and its complications [ J ]. Global Health, 2014, 10(1) : 11. 被引量:1
  • 9Isla Pera P. Chronic complications of diabetes mellitus. Recommen- dations from the American diabetes association 2011. Prevention and management[J]. Rev Enferm, 2012, 35(9): 46-52. 被引量:1
  • 10Ezenwaka C, Eckel J. Prevention of diabetes complications in de- veloping countries: time to intensify self-management education [J]. Arch Physiol Biochem, 2011, 117(5) : 251-253. 被引量:1

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部